Your browser doesn't support javascript.
Tirofiban in emergency conditions.
Szarpak, Lukasz; Rafique, Zubaid; Gasecka, Aleksandra; Jaguszewski, Milosz J; Filipiak, Krzysztof J.
  • Szarpak L; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy in Warsaw, Warsaw, Poland; Maria Sklodowska-Curie Bialystok Oncology Centre, Bialystok, Poland; Polish Society of Disaster Medicine, Warsaw, Poland. Electronic address: lukasz.szarpak@gmail.com.
  • Rafique Z; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Gasecka A; Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
  • Jaguszewski MJ; 1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
  • Filipiak KJ; 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Am J Emerg Med ; 51: 422-423, 2022 01.
Article in English | MEDLINE | ID: covidwho-1157083
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Tirofiban / Myocardial Infarction Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Emerg Med Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Tirofiban / Myocardial Infarction Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Emerg Med Year: 2022 Document Type: Article